Current treatment for anxiety disorder is comprised of generic SSRIs, SNRIs, or benzodiazepines. Patients often goes through a revolving door of different medications with very similar chemical structures. Around 30-40% of patients are unable to find relief after years of trial and error.

Research has now identified the significance of the neurotransmitter Glutamate in the reduction of anxiety. Ketamine is a glutamate inhibitor that reduces the levels of glutamate activity in the hippocampus.

Ketamine has been shown to be 70% effective in patients who have not responded to SSRI class of drugs.